Ethicon Endo-Surgery receives FDA 510(k) clearance for Advanced Energy Generator

In an effort to help simplify the OR, Ethicon Endo-Surgery, Inc. (EES) today announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advanced bipolar technologies and designed for easy set set-up and use in the operating room.

"The operating theatre is a fast-paced and sometimes stressful place," says Judith Butt, Theatre Nurse, Prince Charles Hospital, Wales, UK (the EES Generator launched earlier this year in the UK). "We need technologies that are intuitive to use so we can devote more of our time to the patient's needs."

The new EES Generator has several innovative features that enable the delivery of advanced energy technology and meet the need to simplify the OR including:

  • One unit that powers all current and next generation HARMONIC® ultrasonic and ENSEAL® advanced bipolar devices. This includes the newly launched ENSEAL® G2 Super Jaw technology designed to offer surgeons strong, uniform compression while remaining gentle on thick tissue.  
  • Intuitive touch screen technology display that provides user feedback.
  • More compact and light weight than other generators. Its portable design and optional rolling stand make it easy to move in and around the Operating Room.
  • On-screen diagnostics that provide step-by-step animations, allowing the user to quickly set-up and troubleshoot.
  • Upgradable software feature that gives hospital access to the latest EES energy products and upgrades without the need to purchase additional capital equipment.

"We listened to nurses and surgeons from around the world as we designed the new EES Generator," said Brian Noyes, Global Product Director for the EES Generator, "This new generator is a direct result of that feedback: simplifying the OR by freeing up space, providing an intuitive user interface and troubleshooting to give the surgical team more time to focus on the patient rather than operation of the technology."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer